Will Robinhood Win Tokenization?
For many years, cryptocurrency enthusiasts have predicted a mass tokenization…
Sell
42
DRUG Quote, Financials, Valuation and Earnings
Last price:
$57.01
Seasonality move
:
-8.96%
Day range:
$56.27 - $60.43
52-week range:
$23.18 - $70.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
10.80x
Volume:
207.3K
Avg. volume:
169.3K
1-year change:
34.78%
Market cap:
$410.4M
Revenue:
--
EPS (TTM):
-$0.94
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $4.7K | $53.7K | $53.9K | |
| Gross Profit | -- | -- | -$4.7K | -$53.7K | -$53.9K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $143.8K | $5M | $9.5M | $3.7M | $867.1K | |
| Selling, General & Admin | $213.2K | $829.9K | $806.3K | $295.3K | $224.6K | |
| Other Inc / (Exp) | -- | $121.9K | $8K | $10.5K | -$6.8K | |
| Operating Expenses | $357K | $7M | $11.7M | $5.4M | $2M | |
| Operating Income | -$357K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Net Interest Expenses | -- | -- | -- | $14.6K | $6.6K | |
| EBT. Incl. Unusual Items | -$357K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$357K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$357K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Basic EPS (Cont. Ops) | -$0.28 | -$3.81 | -$4.74 | -$1.47 | -$0.48 | |
| Diluted EPS (Cont. Ops) | -$0.28 | -$3.81 | -$4.74 | -$1.47 | -$0.48 | |
| Weighted Average Basic Share | $1.3M | $1.8M | $2.5M | $3.7M | $4.3M | |
| Weighted Average Diluted Share | $1.3M | $1.8M | $2.5M | $3.7M | $4.3M | |
| EBITDA | -$357K | -$7M | -$11.7M | -$5.4M | -$2M | |
| EBIT | -$357K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$357K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Operating Income (Adjusted) | -$357K | -$7M | -$11.7M | -$5.5M | -$2.1M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $13.5K | $13.2K | $11.4K | |
| Gross Profit | -- | -- | -$13.5K | -$13.2K | -$11.4K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.2M | $1.6M | $782.3K | -$414.2K | $1.9M | |
| Selling, General & Admin | $429K | $133.8K | $118.5K | $59.4K | $201K | |
| Other Inc / (Exp) | $92.9K | $3.3K | -$7.5K | -$14.5K | -- | |
| Operating Expenses | $3M | $2.1M | $1.1M | -$185.7K | $2.4M | |
| Operating Income | -$3M | -$2.1M | -$1.1M | $172.5K | -$2.4M | |
| Net Interest Expenses | -- | -- | $3.4K | $900 | $6.2K | |
| EBT. Incl. Unusual Items | -$2.9M | -$2.1M | -$1.1M | $168K | -$4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -$186.3K | |
| Net Income to Company | -$2.9M | -$2.1M | -$1.1M | $168K | -$3.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.9M | -$2.1M | -$1.1M | $168K | -$3.8M | |
| Basic EPS (Cont. Ops) | -$1.22 | -$0.88 | -$0.29 | $0.04 | -$0.53 | |
| Diluted EPS (Cont. Ops) | -$1.22 | -$0.88 | -$0.29 | $0.04 | -$0.53 | |
| Weighted Average Basic Share | $2.4M | $2.4M | $3.8M | $4.5M | $7.1M | |
| Weighted Average Diluted Share | $2.4M | $2.4M | $3.8M | $4.6M | $7.1M | |
| EBITDA | -$3M | -$2.1M | -$1.1M | $185.7K | -$2.4M | |
| EBIT | -$3M | -$2.1M | -$1.1M | $172.5K | -$2.4M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$3M | -$2.1M | -$1.1M | $172.5K | -$2.4M | |
| Operating Income (Adjusted) | -$3M | -$2.1M | -$1.1M | $172.5K | -$2.4M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $44.8K | $53.5K | $56.5K | |
| Gross Profit | -- | -- | -$44.8K | -$53.5K | -$56.5K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.1M | $9.4M | $4.8M | $1.4M | $4.8M | |
| Selling, General & Admin | $648.6K | $863.6K | $437K | $205.9K | $604.6K | |
| Other Inc / (Exp) | $46.6K | $47.4K | $6.2K | $27.6K | -- | |
| Operating Expenses | $4.7M | $11.8M | $6.5M | $2.6M | $6.4M | |
| Operating Income | -$4.7M | -$11.8M | -$6.6M | -$2.7M | -$6.4M | |
| Net Interest Expenses | -- | -- | $7.3K | $7.5K | $17.6K | |
| EBT. Incl. Unusual Items | -$4.7M | -$11.8M | -$6.6M | -$2.6M | -$6.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -$186.3K | |
| Net Income to Company | -$5M | -$11.8M | -$6.6M | -$2.6M | -$6.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4.7M | -$11.8M | -$6.6M | -$2.6M | -$6.4M | |
| Basic EPS (Cont. Ops) | -$2.32 | -$4.96 | -$1.93 | -$0.68 | -$0.95 | |
| Diluted EPS (Cont. Ops) | -$2.32 | -$4.96 | -$1.93 | -$0.68 | -$0.95 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$4.7M | -$11.8M | -$6.5M | -$2.6M | -$6.4M | |
| EBIT | -$4.7M | -$11.8M | -$6.6M | -$2.7M | -$6.4M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$4.7M | -$11.8M | -$6.6M | -$2.7M | -$6.4M | |
| Operating Income (Adjusted) | -$4.7M | -$11.8M | -$6.6M | -$2.7M | -$6.4M | |
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $40.2K | $39.9K | $42.5K | -- | |
| Gross Profit | -- | -$40.2K | -$39.9K | -$42.5K | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7.6M | $2.9M | $563.6K | $4.5M | -- | |
| Selling, General & Admin | $674.4K | $301.8K | $178.6K | $565.4K | -- | |
| Other Inc / (Exp) | -$31.8K | -$32.3K | -$15.6K | $1.1M | -- | |
| Operating Expenses | $9.4M | $4.2M | $1.4M | $5.8M | -- | |
| Operating Income | -$9.4M | -$4.3M | -$1.5M | -$5.9M | -- | |
| Net Interest Expenses | -- | $7.3K | $4.7K | $15.7K | -- | |
| EBT. Incl. Unusual Items | -$9.5M | -$4.3M | -$1.5M | -$6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$186.3K | -- | |
| Net Income to Company | -$9.5M | -$4.3M | -$1.5M | -$5.9M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.5M | -$4.3M | -$1.5M | -$5.8M | -- | |
| Basic EPS (Cont. Ops) | -$4.00 | -$1.17 | -$0.38 | -$0.82 | -- | |
| Diluted EPS (Cont. Ops) | -$4.00 | -$1.17 | -$0.38 | -$0.82 | -- | |
| Weighted Average Basic Share | $7.1M | $11.1M | $12.8M | $20.3M | -- | |
| Weighted Average Diluted Share | $7.1M | $11.1M | $13M | $20.8M | -- | |
| EBITDA | -$9.4M | -$4.2M | -$1.4M | -$5.8M | -- | |
| EBIT | -$9.4M | -$4.3M | -$1.5M | -$5.9M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$9.4M | -$4.3M | -$1.5M | -$5.9M | -- | |
| Operating Income (Adjusted) | -$9.4M | -$4.3M | -$1.5M | -$5.9M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $598.9K | $15.6M | $8.5M | $5M | $4.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $58.6K | $132.8K | $119.7K | $20.5K | $160.4K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $657.5K | $15.8M | $8.7M | $5M | $4.4M | |
| Property Plant And Equipment | -- | -- | $101.1K | $49.1K | $87.1K | |
| Long-Term Investments | $700 | $26.6K | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $659.7K | $15.8M | $8.8M | $5.1M | $4.5M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | $9.3K | $32.9K | $115.7K | $18.4K | $30.9K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $49.7K | $54.1K | $58.8K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $113K | $504.1K | $1.1M | $207.7K | $391.3K | |
| Long-Term Debt | -- | -- | $52.4K | -- | $29.3K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $113K | $504.1K | $1.1M | $207.7K | $420.6K | |
| Common Stock | $734.2K | $21.4M | $23.5M | $25.1M | $26.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $546.7K | $15.3M | $7.7M | $4.9M | $4.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $546.7K | $15.3M | $7.7M | $4.9M | $4.1M | |
| Total Liabilities and Equity | $659.7K | $15.8M | $8.8M | $5.1M | $4.5M | |
| Cash and Short Terms | $598.9K | $15.6M | $8.5M | $5M | $4.2M | |
| Total Debt | -- | -- | $101.8K | $54.4K | $88.1K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $17.8M | $6.7M | $6.1M | $4.5M | $37.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $103.4K | $62.2K | $107.1K | $42.6K | $519.2K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $17.9M | $6.8M | $6.3M | $4.6M | $38.4M | |
| Property Plant And Equipment | -- | -- | $63.9K | $8.8K | $94.5K | |
| Long-Term Investments | $27.2K | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $1.6K | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $18M | $6.8M | $6.4M | $4.6M | $38.5M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | $11K | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $58.4K | $10.2K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $260.7K | $298.7K | $544.7K | $130.5K | $443.4K | |
| Long-Term Debt | -- | -- | $10.6K | -- | $46.1K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $260.7K | $298.7K | $555.3K | $130.5K | $489.4K | |
| Common Stock | $21.8M | $21.1M | $25.6M | $25.6M | $65.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $17.7M | $6.5M | $5.8M | $4.5M | $38M | |
| Total Liabilities and Equity | $18M | $6.8M | $6.4M | $4.6M | $38.5M | |
| Cash and Short Terms | $17.8M | $6.7M | $6.1M | $4.5M | $37.7M | |
| Total Debt | -- | -- | $69.1K | $10.2K | $103.4K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$357K | -$6.8M | -$11.7M | -$5.5M | -$2.1M | |
| Depreciation & Amoritzation | -- | -- | $4.7K | $53.7K | $53.9K | |
| Stock-Based Compensation | $119.9K | $696.5K | $684.9K | $854.3K | $617.1K | |
| Change in Accounts Receivable | -- | -$87.1K | -$35.7K | $88.1K | -$9.7K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$214.3K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$5.6K | -$63.8K | -$65.9K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.4M | -$626.2K | -$20K | -- | |
| Cash From Financing | $749.4K | $20.6M | $4.1M | $1.6M | $595.7K | |
| Beginning Cash (CF) | $598.9K | $15.5M | $8.4M | $4.9M | $4.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $535K | $15M | -$6.4M | -$3.6M | -$755.4K | |
| Ending Cash (CF) | $1.1M | $30.7M | $2.2M | $1.3M | $3.4M | |
| Levered Free Cash Flow | -$214.3K | -$5.8M | -$10.6M | -$5.2M | -$1.4M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.9M | -$2.1M | -$1.1M | $168K | -$3.9M | |
| Depreciation & Amoritzation | -- | -- | $13.5K | $13.2K | $12.6K | |
| Stock-Based Compensation | $212.4K | $229.8K | $176.9K | $134.4K | $975.1K | |
| Change in Accounts Receivable | -$34K | $87.7K | -$52.4K | $391.7K | -$32.9K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.4M | -$2.2M | -$1.2M | $175.5K | -$2.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | $210 | -$16.2K | -$15.6K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$537.5K | -$220 | -$120 | -- | -- | |
| Cash From Financing | -$444.3K | $9.4K | -$16K | -$16K | $1.3M | |
| Beginning Cash (CF) | $17.7M | $6.6M | $6.1M | $4.5M | $37.6M | |
| Foreign Exchange Rate Adjustment | $61.3K | $18K | $97.1K | $28.9K | -$516.1K | |
| Additions / Reductions | -$2.8M | -$2.2M | -$1.1M | $188.4K | -$1.8M | |
| Ending Cash (CF) | $15M | $4.4M | $5M | $4.7M | $35.3M | |
| Levered Free Cash Flow | -$2.4M | -$2.2M | -$1.2M | $175.5K | -$2.6M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5M | -$11.8M | -$6.6M | -$2.6M | -$6.5M | |
| Depreciation & Amoritzation | -- | -- | $45.1K | $53.5K | $57.7K | |
| Stock-Based Compensation | $530.4K | $965.2K | $578.5K | $761.8K | $1.7M | |
| Change in Accounts Receivable | -$63.5K | $9.7K | -$32K | $58.7K | -$185.2K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.2M | -$10.9M | -$5.9M | -$1.9M | -$5.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$25K | -$28.5K | -$64K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$672.6K | -- | -- | |
| Cash From Financing | $21.9M | $96.8K | $5.5M | $596.2K | $38.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.7M | -$10.6M | -$305.6K | -$1.4M | $33.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$4.2M | -$10.9M | -$5.9M | -$1.9M | -$5.7M | |
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.5M | -$4.3M | -$1.5M | -$5.9M | -- | |
| Depreciation & Amoritzation | -- | $40.2K | $39.9K | $43.7K | -- | |
| Stock-Based Compensation | $666.4K | $555.6K | $463.3K | $1.5M | -- | |
| Change in Accounts Receivable | $35.2K | $37.9K | $9K | -$161K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$9M | -$4.3M | -$1M | -$5.4M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$25K | -$47.9K | -$48.1K | -$33.7K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $26.4K | -$20.1K | -- | -$58.2K | -- | |
| Cash From Financing | $104.5K | $1.6M | $612.4K | $38.7M | -- | |
| Beginning Cash (CF) | $27.6M | $21.4M | $13.8M | $116.4M | -- | |
| Foreign Exchange Rate Adjustment | $164.3K | $88K | -$3.8K | $637.8K | -- | |
| Additions / Reductions | -$8.8M | -$2.6M | -$416.5K | $33.9M | -- | |
| Ending Cash (CF) | $19M | $18.9M | $13.4M | $151M | -- | |
| Levered Free Cash Flow | -$9M | -$4.3M | -$1M | -$5.4M | -- | |
Get DRUG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DRUG
Sector
P/E ratio
--
23.23x
PEG ratio
-1.58x
-0.01x
P/B ratio
10.80x
1.81x
Price / LTM sales
--
1.57x
Growth Metrics
DRUG
Sector
Revenue growth
--
4.93%
Earnings growth
-1564.93%
7.88%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.69
-$0.20
Profitability
DRUG
Sector
Profitability FY 2024
-$53.9K
$3.7M
Return on invested capital
-25.32%
-30.68%
Return on assets
-25.02%
-27.55%
Return on equity
-25.41%
-36.13%
Earnings Date
Last Earnings Date
Nov
16
Next Earnings Date
Dec
22
Estimated Next Earnings Date
Feb
15
Balance Sheet
DRUG
Sector
Total cash
$37.7M
$28.1M
Short term investments
--
$26M
Total assets
$4.5M
$80.3M
Long term debt
$103.4K
$5.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Does DraftKings Stock Have a Moat?
DraftKings (NASDAQ:DKNG) has been one of the largest beneficiaries of…
Is It Time To Buy Unity Stock?
Unity Software (NYSE:U) is the business behind the popular Unity…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
62
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 37x
Alerts
Buy
88
CDTX alert for Nov 15
Cidara Therapeutics, Inc. [CDTX] is up 105.38% over the past day.
Buy
60
SRRK alert for Nov 15
Scholar Rock Holding Corp. [SRRK] is up 24.38% over the past day.
Buy
86
ZCSH alert for Nov 15
Grayscale Zcash Trust (ZEC) [ZCSH] is up 21.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
